Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Adaptive TONIC trial of nivolumab combinations for breast cancer
Dr Marleen Kok - Netherlands Cancer Institute, Amsterdam, Netherlands
Adaptive TONIC trial of nivolumab combinations for breast cancer ( Dr Marleen Kok - Netherlands Cancer Institute, Amsterdam, Netherlands )
9 Sep 2017
Panitumumab triplet therapy in colorectal cancer
Prof Michael Geißler - Klinikum Esslingen, Esslingen am Neckar, Germany
Panitumumab triplet therapy in colorectal cancer ( Prof Michael Geißler - Klinikum Esslingen, Esslingen am Neckar, Germany )
9 Sep 2017
Long term efficacy of denosumab for giant cell bone tumours
Prof Emanuela Palmerini - Rizzoli Orthopedic Institute, Bologna, Italy
Long term efficacy of denosumab for giant cell bone tumours ( Prof Emanuela Palmerini - Rizzoli Orthopedic Institute, Bologna, Italy )
9 Sep 2017
Financial and ethical safety in cancer care
Dr Stefan Rauh - Hospital Center Emile Mayrisch, Esch-sur-Alzette, Luxembourg
Financial and ethical safety in cancer care ( Dr Stefan Rauh - Hospital Center Emile Mayrisch, Esch-sur-Alzette, Luxembourg )
9 Sep 2017
Phase Ib/II trial of combination PD-1 therapy against kidney cancer
Dr Chung-Han Lee - Memorial Sloan Kettering Cancer Center, New York, USA
Phase Ib/II trial of combination PD-1 therapy against kidney cancer ( Dr Chung-Han Lee - Memorial Sloan Kettering Cancer Center, New York, USA )
9 Sep 2017
The UNICANCER-NeoPAL study of letrozole and palbociclib in luminal cancer
Dr Paul Cottu - Institut Curie, Paris, France
The UNICANCER-NeoPAL study of letrozole and palbociclib in luminal cancer ( Dr Paul Cottu - Institut Curie, Paris, France )
9 Sep 2017
Regorafenib versus lomustine for relapsed glioblastoma
Dr Giuseppe Lombardi - Istituto Oncologico Veneto, Padova, Italy
Regorafenib versus lomustine for relapsed glioblastoma ( Dr Giuseppe Lombardi - Istituto Oncologico Veneto, Padova, Italy )
9 Sep 2017
Reviewing LORELEI, mindACT and ExteNET trials in breast cancer
Prof Miguel Martin - Hospital General Universitario Gregorio Marañón, Madrid...
Reviewing LORELEI, mindACT and ExteNET trials in breast cancer ( Prof Miguel Martin - Hospital General Universitario Gregorio Marañón, Madrid, Spain )
9 Sep 2017
PACIFIC trial of durvalumab for stage III NSCLC
Dr Luis Paz-Ares - Hospital Universitario Doce de Octubre, Madrid, Spain
PACIFIC trial of durvalumab for stage III NSCLC ( Dr Luis Paz-Ares - Hospital Universitario Doce de Octubre, Madrid, Spain )
9 Sep 2017
Osimertinib suitable for first line EGFRm lung cancer
Dr Suresh Ramalingam - Winship Cancer Institute, Atlanta, USA
Osimertinib suitable for first line EGFRm lung cancer ( Dr Suresh Ramalingam - Winship Cancer Institute, Atlanta, USA )
9 Sep 2017
PACIFIC trial of durvalumab for lung cancer
Dr Luis Paz-Ares - Hospital Universitario Doce de Octubre, Madrid, Spain
PACIFIC trial of durvalumab for lung cancer ( Dr Luis Paz-Ares - Hospital Universitario Doce de Octubre, Madrid, Spain )
9 Sep 2017
ESMO 2017: CDK4/6 inhibitors from a patient’s perspective
Prof Kimberly Blackwell, Prof Hope Rugo, Prof Peter Schmid, Dr Mark Verrill
ESMO 2017: CDK4/6 inhibitors from a patient’s perspective ( Prof Kimberly Blackwell, Prof Hope Rugo, Prof Peter Schmid, Dr Mark Verrill )
8 Sep 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation